Failure of the Ottawa Score to predict the risk of recurrent venous thromboembolism in cancer patients: the prospective PREDICARE cohort study

P Girard, S Laporte, C Chapelle, N Falvo… - Thrombosis and …, 2022 - thieme-connect.com
Introduction Recurrent venous thromboembolism (VTE) despite curative anticoagulation is
frequent in patients with cancer. Identifying patients with a high risk of recurrence could have …
被引用次数：20 相关文章

Failure of the Ottawa Score to Predict the Risk of Recurrent Venous Thromboembolism in Cancer Patients: The Prospective PREDICARE Cohort Study

P Girard, S Laporte, C Chapelle… - Thrombosis and …, 2022 - pubmed.ncbi.nlm.nih.gov
Introduction Recurrent venous thromboembolism (VTE) despite curative anticoagulation is
frequent in patients with cancer. Identifying patients with a high risk of recurrence could have …

Failure of the Ottawa Score to Predict the Risk of Recurrent Venous Thromboembolism in Cancer Patients: The Prospective PREDICARE Cohort Study

P Girard, S Laporte, C Chapelle, N Falvo… - Thrombosis and …, 2021 - thieme-connect.com
Introduction Recurrent venous thromboembolism (VTE) despite curative anticoagulation is
frequent in patients with cancer. Identifying patients with a high risk of recurrence could have …

Failure of the Ottawa Score to Predict the Risk of Recurrent Venous Thromboembolism in Cancer Patients: The Prospective PREDICARE Cohort Study.

P Girard, S Laporte, C Chapelle, N Falvo… - Thrombosis and …, 2021 - europepmc.org
Methods In a prospective multicenter observational cohort, adult cancer patients with a
recent diagnosis of symptomatic or incidental lower limb deep vein thrombosis or pulmonary …